アジア太平洋地域のエキソソーム研究製品市場、製品別（機器および消耗品）、適応症別（がんおよび非がん）、用途別（治療薬および診断薬）、エンドユーザー別（病院、臨床検査研究所、研究センター、製薬およびバイオテクノロジー企業、学術機関、その他）、流通チャネル別（サードパーティの販売代理店、オンライン、直接入札）の業界動向および2030年までの予測。
アジア太平洋地域のエクソソーム研究製品市場分析と洞察
がんやさまざまな自己免疫疾患の罹患率と発症率の増加により、市場の需要が高まっています。主要な市場プレーヤーは、この重要な時期にさまざまなサービスの立ち上げと承認に重点を置いています。さらに、製薬研究開発とライフサイエンス研究への投資の増加も、エキソソーム研究製品のテストに対する需要の高まりに貢献しています。
アジア太平洋地域のエクソソーム研究製品市場は、市場プレーヤーの増加と高度なサービスの利用可能性により、予測年度に成長すると予想されています。これに伴い、メーカーは市場で新しいサービスを開始するための研究開発活動に取り組んでいます。
しかし、エクソソームの開発と製造に関するゴールドスタンダードのプロトコルが欠如しているため、予測期間中のアジア太平洋地域のエクソソーム研究製品市場の成長が妨げられる可能性があります。
エクソソーム技術のさらなる進歩により、市場に治療を強化する機会が生まれることが期待されます。
しかし、エクソソーム研究製品に伴う副作用や製品発売に伴う承認の遅れが、市場の成長を妨げる可能性があります。
データブリッジマーケットリサーチは、アジア太平洋地域のエクソソーム研究製品市場は、予測期間中に40.3%のCAGRで成長し、2030年までに5,68,432.59千米ドルに達すると予測しています。診断および治療におけるエクソソーム研究製品の使用が増加しているため、製品は市場で最大のタイプセグメントを占めています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 |
|
定量単位 |
売上高は千米ドル、販売数量は個数、価格は米ドル |
|
対象セグメント |
製品別（機器および消耗品）、適応症別（がんおよび非がん）、用途別（治療薬および診断薬）、エンドユーザー別（病院、臨床検査研究所、研究センター、製薬およびバイオテクノロジー企業、学術機関、その他）、流通チャネル別（サードパーティの販売代理店、オンライン、直接入札） |
|
対象国 |
中国、日本、インド、韓国、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、ベトナム、その他アジア太平洋地域 |
|
対象となる市場プレーヤー |
アジア太平洋地域のエクソソーム研究製品市場で活動している主要企業には、Hologic Inc.、Luminex Corporation、Thermo Fisher Scientific、Agilent Technologies、Inc.、Microgentas、Cell Guidance Systems LLC、QIAGEN、FUJIFILM Irvine Scientific（富士フイルムホールディングス株式会社の子会社）、CUSABIO TECHNOLOGY LLC、Norgen Biotek Corp.、Miltenyi Biotec、Novus Biologicals、Beckman Coulter、Inc.、JSR Micro NV、Hitachi、Ltd.、INOVIQ、Audubon Bioscienceなどがあります。 |
アジア太平洋地域のエクソソーム研究製品市場の定義
エクソソームは、エンドソームで構成される細胞由来の細胞外小胞の特定のクラスであり、通常、直径は 30 ～ 150 nm で、最も小さいタイプの細胞外小胞です。脂質二重層で保護されたエクソソームは、元の細胞に由来する複雑な貨物を内包して細胞外環境に押し出されます。貨物に含まれる内容物は、タンパク質、脂質、メッセンジャーリボ核酸 (mRNA)、ミクロソームリボ核酸 (miRNA)、およびデオキシリボ核酸 (DNA) です。
エクソソームは、自己免疫疾患などのさまざまな慢性疾患の治療に利用されています。エクソソーム療法は、薬物送達、腫瘍免疫療法、診断バイオマーカーに広く使用されています。エクソソームは、その小さなサイズ、天然の性質、および生物学的障壁を越える能力により、薬物キャリアとして使用されています。
アジア太平洋地域のエクソソーム研究製品市場の動向
このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。
ドライバー
- 癌、慢性炎症、自己免疫疾患、ライム病、その他の慢性変性疾患の罹患率の増加
WHOによると、がんは世界的に死亡原因のトップであり、2020年には約1,000万人が亡くなりました。インドでは、2020年の男性のがん患者数は約679,421人、女性は約712,758人でした。2021年の米国の新規がん症例数と死亡者数は約190万人、がんによる死亡者は608,570人でした。このように、がんの発生率は研究者にますます多くの研究を促しており、バイオマーカーはがんの診断に役立ちます。したがって、市場の成長が加速しています。
したがって、結論として、心血管疾患、神経疾患、その他のさまざまな慢性疾患などの慢性疾患の増加により、さまざまな医薬品の需要が増加し、今後数年間でアジア太平洋地域のエクソソーム研究製品市場の成長を促進することになります。
- 医薬品研究開発およびライフサイエンス研究への投資の増加
学術研究機関、製薬およびバイオテクノロジー企業、病院、臨床検査研究所が市場の主なエンドユーザーです。近年、エクソソーム研究の需要が高まっています。これは、エクソソームが病気の検出に潜在的であり、細胞間メッセンジャーとしての役割が新たに出現しているためです。これが多くの学術研究者の関心を集め、市場の成長につながっています。2022年の製薬研究開発費の動向によると、現在、世界中で6,000以上の項目が臨床試験で検査されており、2016年と比較して68％増加しています。
市場プレーヤーが研究開発活動に絶えず取り組んでいるため、アジア太平洋地域のエクソソーム研究製品市場では、より多くのハイブリッドおよび天然エクソソームが導入されています。これにより、病院や診断センターでの癌や自己免疫疾患の治療のためのエクソソーム治療薬の需要が高まります。したがって、研究開発活動の進歩と製薬分野への投資の増加が、市場全体の成長を促進すると予想されます。
拘束
- エクソソームの開発と生産のためのゴールドスタンダードプロトコルの欠如
エクソソームの分野はまだ初期段階にあり、これまでのところゴールドスタンダードは開発されていません。そのため、専門家はためらうことなく市場の新しい手順と方法論を採用しています。研究者がエクソソームの製造中にミスを犯すだけでなく、科学者はエクソソームの研究開発と製造活動においてさまざまな課題に直面しています。
エクソソームの認証と安全性の欠如は、安全プロトコルと天然およびハイブリッドエクソソームの生産を妨げることになります。したがって、エクソソームの開発における標準プロトコルの欠如とエクソソームの分離に対する認証要件の欠如は、エクソソーム研究製品市場の成長を抑制すると予想されます。
機会
-
エンドユーザーの間で専門的なテストサービスの需要が増加
エクソソームは、高度な RNA とタンパク質のカーゴを含む小さな (30～150 nm) 小胞で、体外および体内のすべての細胞から絶えず分泌されます。エクソソームは、細胞間コミュニケーションやシグナル伝達など、人体内の興味深い機能により、研究に変化をもたらしています。
今後、液体クロマトグラフィー質量分析、RNA シーケンシング、湿式化学、遺伝子発現、その他のさまざまなテスト サービスなどの専門的なテスト サービスの利用の増加が、エキソソーム研究製品市場の成長の原動力となり、これらのテスト サービスが正確な結果を正確に提供できることで、エンド ユーザーの間で需要が高まっています。
チャレンジ
- エクソソーム研究製品に関連する副作用
While all medical treatments have benefits and risks, unapproved exosome products expose patients to potential risks without a clear benefit. These products may potentially treat many medical conditions and diseases, but further research is needed to know whether the products have any benefit or are safe to use. The side effects may include injection site reaction, failure of the cells to work as expected, growth of tumors, infections, and the potential for contamination of the product, the ability of cells to move from placement sites and multiply or change into inappropriate cell types
Henceforth, the various side effects of exosome research products for their diagnosis safety, cost, and convenience issues are expected to challenge the Asia-Pacific exosome research products market.
Recent Developments
- In July 2022, Aethlon Medical, Inc., a medical therapy company focused on developing products for the diagnosis and treatment of cancer and life-threatening infectious diseases, announced that the US Food and Drug Administration (FDA) had approved a protocol amendment for an ongoing clinical trial of Aethlon Hemopurifier for patients with severe COVID-19
- In April 2020, ExoDX launched the ExoDx Prostate Test Home Collection Kit for patients concerned about prostate health. The home collection kit provides an immediate and cost-effective solution that enables a telemedicine/telehealth option for physicians and their patients who share the frustration, anxiety, and fear of the advanced prostate cancer patient
Asia-Pacific Exosome Research Products Market Scope
Asia-Pacific exosome research products market is segmented into five notable segments such as product, indication, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT
- INSTRUMENTS
- Consumables
On the basis of product, the Asia-Pacific exosome research products market is segmented into instruments and consumables.
ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION
- CANCER
- NON CANCER
On the basis of indication, the Asia-Pacific exosome research products market is segmented into cancer and non-cancer.
ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION
- THERAPEUTICS
- DIAGNOSTICS
On the basis of application, the Asia-Pacific exosome research products market is segmented into therapeutics and diagnostics.
ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USERS
- HOSPITALS
- CLINICAL TESTING LABORATORIES
- RESEARCH CENTERS
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
- ACADEMIC INSTITUTES
- OTHERS
On the basis of end users, the Asia-Pacific exosome research products market is segmented into hospitals, clinical testing laboratory, research centers, pharmaceutical and biotechnology company, academic institutes, and others.
アジア太平洋地域のエクソソーム研究製品市場（流通チャネル別）
- サードパーティディストリビューター
- オンライン
- 直接入札
流通チャネルに基づいて、アジア太平洋地域のエクソソーム研究製品市場は、サードパーティの販売代理店、オンライン、直接入札に分類されます。
アジア太平洋地域のエクソソーム研究製品市場の地域分析/洞察
アジア太平洋地域のエクソソーム研究製品市場は、製品、適応症、用途、エンドユーザー、流通チャネルなど、5 つの主要なセグメントに分類されています。
この市場レポートで取り上げられている国は、中国、日本、インド、韓国、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、ベトナム、およびその他のアジア太平洋諸国です。
中国は、研究開発への投資の増加により市場の成長が促進されることから、アジア太平洋地域を支配すると予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と国内規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、アジア太平洋ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
競争環境とアジア太平洋地域のエクソソーム研究製品の市場シェア分析
アジア太平洋のエクソソーム研究製品市場の競争環境は、競合他社の詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線が含まれます。上記のデータポイントは、アジア太平洋のエクソソーム研究製品市場への会社の重点にのみ関連しています。
アジア太平洋地域のエクソソーム研究製品市場で活動している主要企業としては、Hologic Inc.、Luminex Corporation、Thermo Fisher Scientific、Agilent Technologies, Inc.、Microgentas、Cell Guidance Systems LLC、QIAGEN、FUJIFILM Irvine Scientific（富士フイルムホールディングス株式会社の子会社）、CUSABIO TECHNOLOGY LLC、Norgen Biotek Corp.、Miltenyi Biotec、Novus Biologicals、Beckman Coulter, Inc.、JSR Micro NV、日立製作所、INOVIQ、Audubon Bioscience などが挙げられます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 SUPPLY CHAIN ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 BUSINESS STRATEGY EXCELLENCE
4.6 CASE STUDIES
4.7 STRENGTH OF PRODUCT PORTFOLIO
4.8 TECHNOLOGICAL TRENDS
4.9 PRICING ANALYSIS
5 INDUSTRY INSIGHTS
6 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES
7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH
7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME
7.2 RESTRAINTS
7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES
7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME
7.3 OPPORTUNITIES
7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS.
7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS
7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES
8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CONSUMABLES
8.2.1 KITS AND REAGENTS
8.2.1.1 EXOSOME BIOMARKER KITS
8.2.1.2 EXOSOME ISOLATION KITS
8.2.1.3 EXOSOME PURIFICATION KITS
8.2.1.4 EXOSOME QUANTITATIVE KITS
8.2.1.5 EXOSOME DETECTION KITS
8.2.1.6 OTHERS
8.2.2 EXOSOME STANDARDS
8.2.3 EXOSOME ANTIBODIES
8.2.4 CELL LINES
8.2.5 IMMUNOPLATES
8.2.6 IMMUNOBEADS
8.2.7 BIOFLUIDS
8.2.8 OTHERS
8.3 INSTRUMENTS
8.3.1 BENCHTOP
8.3.2 STANDALONE
9 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION
9.1 OVERVIEW
9.2 CANCER
9.2.1 LUNG CANCER
9.2.2 BREAST CANCER
9.2.3 COLORECTAL CANCER
9.2.4 PROSTATE CANCER
9.2.5 OTHER CANCER
9.3 NON-CANCER
9.3.1 CARDIOVASCULAR DISEASE
9.3.2 NEURODEGENERATIVE DISEASE
9.3.3 INFECTIOUS DISEASE
9.3.4 OTHERS
10 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION
10.1 OVERVIEW
10.2 THERAPEUTICS
10.3 CONSUMABLES
10.4 INSTRUMENTS
10.5 DIAGNOSIS
10.6 CONSUMABLES
10.7 INSTRUMENTS
11 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER
11.1 OVERVIEW
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
11.3 CONSUMABLES
11.4 INSTRUMENTS
11.5 RESEARCH CENTRES
11.6 CONSUMABLES
11.7 INSTRUMENTS
11.8 ACADEMIC INSTITUTES
11.9 CONSUMABLES
11.1 INSTRUMENTS
11.11 CLINICAL TESTING LABORATORY
11.12 CONSUMABLES
11.13 INSTRUMENTS
11.14 HOSPITALS
11.15 CONSUMABLES
11.16 INSTRUMENTS
11.17 OTHERS
12 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 THIRD PARTY DISTRIBUTORS
12.3 DIRECT SALES
12.4 ONLINE
13 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 SINGAPORE
13.1.7 MALAYSIA
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 NEW ZEALAND
13.1.12 VIETNAM
13.1.13 TAIWAN
13.1.14 REST OF ASIA-PACIFIC
14 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 THERMO FISHER SCIENTIFIC INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 EXODX (ACQUIRED BY BIO-TECHNE)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 MILTENYI BIOTEC
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 LUMINEX CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 RECENT DEVELOPMENT
16.5 HOLOGIC, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AETHLON MEDICAL, INC. (2022)
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 AGILENT TECHNOLOGIES, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 AMSBI0
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 AUDUBON BIOSCIENCE.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC)
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 COMPANY SHARE ANALYSIS
16.11.4 PRODUCT PORTFOLIO
16.11.5 RECENT DEVELOPMENT
16.12 CELL GUIDANCE SYSTEMS LLC
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 CREATIVE BIOARRAY
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 CUSABIO TECHNOLOGY LLC
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 HBMLS (ACQUIRED BY LONZA)
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 HITACHI, LTD.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 INOVIQ
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 JSR MICRO NV
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 MICROGENTAS
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 NANOSOMIX
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 NEXOSOME-ONCOLOGY
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 NORGEN BIOTEK CORP.
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NOVUS BIOLOGICALS
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 PROTEOGENEX
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 QIAGEN
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENT
16.27 ROOSTERBIO, INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENTS
16.28 SYSTEM BIOSCIENCES, LLC.
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
表のリスト
TABLE 1 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS
TABLE 2 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND)
TABLE 3 ASIA PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 ASIA PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 5 ASIA PACIFIC KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 6 ASIA PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 ASIA PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 9 ASIA PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 ASIA PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 11 ASIA PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 ASIA PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 13 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 14 ASIA PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 ASIA PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 16 ASIA PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 ASIA PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 18 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 19 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 21 ASIA PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 ASIA PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 23 ASIA PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 ASIA PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 25 ASIA PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 ASIA PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 27 ASIA PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 ASIA PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 29 ASIA PACIFIC OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 30 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 31 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 ASIA PACIFIC DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 ASIA PACIFIC ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 52 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 53 CHINA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 54 CHINA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 55 CHINA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 56 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 57 CHINA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 58 CHINA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 59 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 60 CHINA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 61 CHINA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 62 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 63 CHINA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 64 CHINA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 65 CHINA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 66 CHINA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 67 CHINA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 68 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 69 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 70 JAPAN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 71 JAPAN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 72 JAPAN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 73 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 74 JAPAN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 75 JAPAN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 76 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 77 JAPAN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 78 JAPAN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 79 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 80 JAPAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 81 JAPAN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 82 JAPAN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 83 JAPAN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 84 JAPAN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 85 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 86 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 87 INDIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 88 INDIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 89 INDIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 90 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 91 INDIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 92 INDIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 93 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 94 INDIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 95 INDIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 96 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 97 INDIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 98 INDIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 99 INDIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 100 INDIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 101 INDIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 102 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 103 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 104 SOUTH KOREA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 105 SOUTH KOREA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 106 SOUTH KOREA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 107 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 108 SOUTH KOREA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 109 SOUTH KOREA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 110 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 111 SOUTH KOREA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 112 SOUTH KOREA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 113 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 114 SOUTH KOREA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 115 SOUTH KOREA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 116 SOUTH KOREA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 117 SOUTH KOREA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 118 SOUTH KOREA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 119 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 120 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 121 AUSTRALIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 122 AUSTRALIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 123 AUSTRALIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 124 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 125 AUSTRALIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 126 AUSTRALIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 127 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 128 AUSTRALIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 129 AUSTRALIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 130 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 131 AUSTRALIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 132 AUSTRALIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 133 AUSTRALIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 134 AUSTRALIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 135 AUSTRALIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 136 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 137 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 138 SINGAPORE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 139 SINGAPORE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 140 SINGAPORE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 141 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 142 SINGAPORE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 143 SINGAPORE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 144 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 145 SINGAPORE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 146 SINGAPORE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 147 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 148 SINGAPORE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 149 SINGAPORE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 150 SINGAPORE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 151 SINGAPORE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 152 SINGAPORE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 153 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 154 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 155 MALAYSIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 156 MALAYSIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 157 MALAYSIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 158 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 159 MALAYSIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 160 MALAYSIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 161 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 162 MALAYSIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 163 MALAYSIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 164 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 165 MALAYSIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 166 MALAYSIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 167 MALAYSIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 168 MALAYSIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 MALAYSIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 170 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 171 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 172 THAILAND CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 173 THAILAND KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 174 THAILAND INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 175 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 176 THAILAND CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 177 THAILAND NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 178 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 179 THAILAND THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 180 THAILAND DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 181 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 182 THAILAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 183 THAILAND RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 184 THAILAND ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 185 THAILAND CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 186 THAILAND HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030
TABLE 187 THAILAND EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 188 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 189 INDONESIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 190 INDONESIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 191 INDONESIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 192 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 193 INDONESIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 194 INDONESIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 195 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 196 INDONESIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 197 INDONESIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 198 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 199 INDONESIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 200 INDONESIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 201 INDONESIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 202 INDONESIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 203 INDONESIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 204 INDONESIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 205 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 206 PHILIPPINES CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 207 PHILIPPINES KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 208 PHILIPPINES INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 209 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 210 PHILIPPINES CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 211 PHILIPPINES NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 212 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 213 PHILIPPINES THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 214 PHILIPPINES DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 215 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 216 PHILIPPINES PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 217 PHILIPPINES RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 218 PHILIPPINES ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 219 PHILIPPINES CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 220 PHILIPPINES HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 221 PHILIPPINES EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 222 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 223 NEW ZEALAND CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 224 NEW ZEALAND KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 225 NEW ZEALAND INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 226 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 227 NEW ZEALAND CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 228 NEW ZEALAND NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 229 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 230 NEW ZEALAND THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 231 NEW ZEALAND DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 232 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 233 NEW ZEALAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 234 NEW ZEALAND RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 235 NEW ZEALAND ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 236 NEW ZEALAND CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 237 NEW ZEALAND HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 238 NEW ZEALAND EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 239 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 240 VIETNAM CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 241 VIETNAM KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 242 VIETNAM INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 243 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 244 VIETNAM CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 245 VIETNAM NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 246 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 247 VIETNAM THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 248 VIETNAM DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 249 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 250 VIETNAM PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 251 VIETNAM RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 252 VIETNAM ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 253 VIETNAM CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 254 VIETNAM HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 255 VIETNAM EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 256 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 257 TAIWAN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 258 TAIWAN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 259 TAIWAN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 260 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 261 TAIWAN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 262 TAIWAN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 263 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 264 TAIWAN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 265 TAIWAN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 266 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 267 TAIWAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 268 TAIWAN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 269 TAIWAN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 270 TAIWAN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 271 TAIWAN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 272 TAIWAN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 273 REST OF ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
図表一覧
FIGURE 1 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET
FIGURE 14 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022
FIGURE 15 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND)
FIGURE 16 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022
FIGURE 19 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND)
FIGURE 20 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030)
FIGURE 21 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022
FIGURE 23 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 24 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022
FIGURE 27 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 28 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 32 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022)
FIGURE 35 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022)
FIGURE 36 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030)
FIGURE 39 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
